Sexually Transmitted Infections

Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.

A chlamydia infection makes HIV acquisition more likely.

Plans to expand the program to the entire state are underway.

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.

Could home-based self-swabs and mobile technology be helpful tools in the future of HIV prevention?

No meaningful difference was found in either injectable or implant birth control when compared to an IUD.

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

Rectal and throat tests matter too, and providers should be recommending them.